Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 20;16(8):e0256522.
doi: 10.1371/journal.pone.0256522. eCollection 2021.

Primary kidney disease modifies the effect of comorbidities on kidney replacement therapy patients' survival

Affiliations

Primary kidney disease modifies the effect of comorbidities on kidney replacement therapy patients' survival

Jaakko Helve et al. PLoS One. .

Abstract

Background: Comorbidities are associated with increased mortality among patients receiving long-term kidney replacement therapy (KRT). However, it is not known whether primary kidney disease modifies the effect of comorbidities on KRT patients' survival.

Methods: An incident cohort of all patients (n = 8696) entering chronic KRT in Finland in 2000-2017 was followed until death or end of 2017. All data were obtained from the Finnish Registry for Kidney Diseases. Information on comorbidities (coronary artery disease, peripheral vascular disease, left ventricular hypertrophy, heart failure, cerebrovascular disease, malignancy, obesity, underweight, and hypertension) was collected at the start of KRT. The main outcome measure was relative risk of death according to comorbidities analyzed in six groups of primary kidney disease: type 2 diabetes, type 1 diabetes, glomerulonephritis (GN), polycystic kidney disease (PKD), nephrosclerosis, and other or unknown diagnoses. Kaplan-Meier estimates and Cox regression were used for survival analyses.

Results: In the multivariable model, heart failure increased the risk of death threefold among PKD and GN patients, whereas in patients with other kidney diagnoses the increased risk was less than twofold. Obesity was associated with worse survival only among GN patients. Presence of three or more comorbidities increased the age- and sex-adjusted relative risk of death 4.5-fold in GN and PKD patients, but the increase was only 2.5-fold in patients in other diagnosis groups.

Conclusions: Primary kidney disease should be considered when assessing the effect of comorbidities on survival of KRT patients as it varies significantly according to type of primary kidney disease.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Effect of the number of comorbidities on unadjusted survival probability according to primary kidney disease.

References

    1. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet. 1993; 341: 415–418. doi: 10.1016/0140-6736(93)93003-j - DOI - PubMed
    1. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al.. Association of Comorbid Conditions and Mortality in Hemodialysis Patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14: 3270–3277. doi: 10.1097/01.asn.0000100127.54107.57 - DOI - PubMed
    1. Helve J, Haapio M, Groop PH, Grönhagen-Riska C, Finne P. Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy. Diabetologia. 2011; 54: 1663–1669. doi: 10.1007/s00125-011-2140-6 - DOI - PubMed
    1. Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, et al.. Changes in co-morbidity patterns in patients starting renal replacement therapy in Europe–data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2018; 33:1794–1804. doi: 10.1093/ndt/gfx355 - DOI - PubMed
    1. Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, et al.. Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011; 57: 894–902. doi: 10.1053/j.ajkd.2010.12.023 - DOI - PMC - PubMed

MeSH terms